Literature DB >> 2100349

Cardiopulmonary adjustments during operant heart rate control.

J P Hatch1, S Borcherding, L K Norris.   

Abstract

Twenty-three healthy men and women participated in a 5-session experiment in which they attempted to increase and decrease their heart rate with the assistance of visual analogue biofeedback. As a group subjects did successfully raise and lower heart rate from resting baseline. These changes in heart rate were closely paralleled by changes in V, a measure of cardiac vagal tone. Heart rate slowing was associated with increases in V, and heart rate speeding was associated with decreases in V. Respiration rate and amplitude did not differ significantly between heart rate slowing and speeding trials, and covariance analysis indicated that respiratory changes did not account for the heart rate or V effects. The weighted coherence between respiration and heart rate showed that cardiopulmonary coupling increased during heart rate slowing and decreased during heart rate speeding. Individual differences in cardiac vagal tone and cardiopulmonary coupling were unrelated to heart rate speeding and slowing performance.

Entities:  

Mesh:

Year:  1990        PMID: 2100349     DOI: 10.1111/j.1469-8986.1990.tb03185.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  3 in total

1.  Cardiac sympathetic and parasympathetic activity during self-regulation of heart period.

Authors:  J P Hatch; S Borcherding; C German
Journal:  Biofeedback Self Regul       Date:  1992-06

2.  Regulation of mental states and biofeedback techniques: effects on breathing pattern.

Authors:  B Blumenstein; I Breslav; M Bar-Eli; G Tenenbaum; Y Weinstein
Journal:  Biofeedback Self Regul       Date:  1995-06

3.  What Physiological Changes and Cerebral Traces Tell Us about Adhesion to Fiction During Theater-Watching?

Authors:  Marie-Noëlle Metz-Lutz; Yannick Bressan; Nathalie Heider; Hélène Otzenberger
Journal:  Front Hum Neurosci       Date:  2010-08-19       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.